Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Coherus
Biotech
Coherus axes TIGIT program 2 years after making $35M bet
The decision follows an analysis of data from a trial of the TIGIT candidate and results in rival programs.
Nick Paul Taylor
Jan 10, 2024 7:50am
Surface warns bankruptcy possible if shareholders reject merger
Aug 2, 2023 10:00am
Coherus scratches the Surface with $65M buy
Jun 16, 2023 10:45am
Coherus slashes staff by a third after biosimilar knockback
Jun 29, 2017 9:48am
Coherus' Amgen biosimilar is rejected by FDA; stock plummets
Jun 12, 2017 8:44am
Shire bails out of Baxalta biosimilars, ends Coherus, Momenta deals
Sep 27, 2016 10:09am
